Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07115576

Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: A Prospective Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
106 (estimated)
Sponsor
Hue University of Medicine and Pharmacy · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Title: Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: A Prospective Study Purpose: The goal of this clinical trial is to learn if single-session radiofrequency ablation (RFA) can effectively reduce the volume of benign thyroid nodules in adults. It will also evaluate the safety of the RFA procedure. The main questions it aims to answer are: 1. Does RFA procedure reduce the size of thyroid nodules (measured by volume reduction rate - VRR)? 2. What medical problems or complications do participants experience after undergoing RFA? 3. How does RFA affect thyroid hormone levels (TSH, FT4)? 4. Is RFA equally effective in purely cystic nodules, solid nodules, and predominantly cystic nodules? Comparator: This is a single-arm study, so there is no placebo or comparison treatment group. All participants will undergo RFA, and the results will be assessed over time. Participants will: * Undergo one session of RFA for benign thyroid nodules. * Be followed up with clinical visits and ultrasound assessments at 1, 6, and 12 months. * Have thyroid hormone levels tested and nodule size measured by ultrasound at each follow-up. * Be monitored for any side effects or complications such as voice changes, pain, or bleeding.

Conditions

Interventions

TypeNameDescription
PROCEDURERadiofrequency ablation aloneRadiofrequency ablation (RFA) is a minimally invasive procedure used to treat benign thyroid nodules without surgery. It involves inserting a thin, needle-like electrode into the nodule under ultrasound guidance. Using high-frequency alternating current, the electrode generates heat to destroy targeted thyroid tissue, causing the nodule to shrink over time.

Timeline

Start date
2023-02-10
Primary completion
2026-02-10
Completion
2026-04-10
First posted
2025-08-11
Last updated
2025-12-16

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT07115576. Inclusion in this directory is not an endorsement.